CRON - Cronos Group Inc.
IEX Last Trade
2.01
-0.260 -12.935%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:14:47 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$2.27
-0.26
-11.45%
Fundamental analysis
20%
Profitability
0%
Dept financing
1%
Liquidity
75%
Performance
30%
Performance
5 Days
2.56%
1 Month
-6.10%
3 Months
-3.85%
6 Months
-11.89%
1 Year
0.50%
2 Year
-19.68%
Key data
Stock price
$2.01
DAY RANGE
$2.02 - $2.27
52 WEEK RANGE
$1.95 - $3.14
52 WEEK CHANGE
-$1.48
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Michael R. Gorenstein
Region: US
Website: thecronosgroup.com
Employees: 450
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: thecronosgroup.com
Employees: 450
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for medical and adult-use markets.
Recent news